| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 03/10/2005 | WO2005021490A2 N-SULFONYL-α-AMINO-ACID DERIVATIVES |
| 03/10/2005 | WO2005021486A1 Ester derivative and medicinal use thereof |
| 03/10/2005 | WO2005020899A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 03/10/2005 | WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/10/2005 | WO2004112793B1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
| 03/10/2005 | WO2004099148A8 Substituted pyrimidine derivatives |
| 03/10/2005 | WO2004096128A3 Hiv integrase inhibitors |
| 03/10/2005 | WO2004082613A3 2,4-diamino-5-[5’-substituted-benzyl] pyrimidines and 2,4-diamino-6-[5’-substituted-benzyl] quinazolines |
| 03/10/2005 | US20050054819 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis |
| 03/10/2005 | US20050054732 Preventives or remidies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds |
| 03/10/2005 | US20050054715 Vinyl phenyl derivatives as glk activators |
| 03/10/2005 | US20050054662 Quinazoline derivatives as antitumor agents |
| 03/10/2005 | US20050054661 Irritable bowel disorders; anxiolytic agents; antidepressants |
| 03/10/2005 | US20050054660 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors |
| 03/10/2005 | US20050054656 Therapy for obesity, eating disorders, psychological disorders, antidepressants, central nervous system disorders |
| 03/10/2005 | US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 03/10/2005 | US20050054643 Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
| 03/10/2005 | US20050054638 Anticancer agents |
| 03/10/2005 | US20050054626 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| 03/10/2005 | US20050054534 Substituted benzoylcyclohexane diones for use as herbicides |
| 03/10/2005 | US20050051052 Self-assembling dyes |
| 03/10/2005 | CA2536788A1 Naphthalene carboxamides and their derivatives useful as new anti-angiogenic agents |
| 03/10/2005 | CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/09/2005 | EP1511730A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 03/09/2005 | EP0906291B1 Substituted phenyl uracils |
| 03/09/2005 | CN1592743A Inhibitors of glycogen synthase kinase 3 |
| 03/09/2005 | CN1592735A Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives |
| 03/09/2005 | CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
| 03/08/2005 | US6864397 E.g., 1-(4-(4-pentylcyclohexyl)cyclohexyldifluoromethoxy)-4 -trifluoromethoxybenzene; preparation from difluorocyclo-hexylidenes, e.g. 1-(4-(trans-4-propylcyclohexyl)cyclohexyl-difluoromethoxy)-3,4,5 -trifluorobenzene; liquid crystals |
| 03/08/2005 | US6864369 New crystal structure of lopinavir; enzyme inhibitors of human immunodeficiency virus (HIV) protease for treating HIV infections |
| 03/08/2005 | US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases |
| 03/08/2005 | US6864289 Insecticides |
| 03/08/2005 | US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy |
| 03/08/2005 | US6863838 Low melting point |
| 03/03/2005 | WO2005019207A1 Fungicidal pyrimidine derivatives |
| 03/03/2005 | WO2005019194A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 03/03/2005 | WO2005019187A1 2-substituted pyrimidines |
| 03/03/2005 | WO2005019174A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 03/03/2005 | WO2005019151A1 Ppar modulators |
| 03/03/2005 | WO2005019147A2 Pesticidally active phenol derivatives |
| 03/03/2005 | WO2005003098B1 Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents |
| 03/03/2005 | US20050049264 Suppressing growth of abnormal cells; gastric, brain, colon, pancreatic, lung, renal, ovarian and prostatic cancer |
| 03/03/2005 | US20050049262 Substituted 2,5-dioxopurines, 2H-1,2,3-triazolyl[4,5-d]pyrimidines, or 1,2,5-thadiazolyl[3,4-d]pyrimidines; antiproliferative, antiinflammatory, and antiarthritic agents; psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, lupus, graft versus host disease |
| 03/03/2005 | US20050049251 Inhibitors of p38 |
| 03/03/2005 | US20050049247 Pyrimidines useful as modulators of voltage-gated ion channels |
| 03/03/2005 | DE10207376B4 Verfahren zur Herstellung von 2-Anilino-4,6-dimethylpyrimidin A process for the preparation of 2-anilino-4,6-dimethylpyrimidine |
| 03/03/2005 | CA2536313A1 Fused pyrimidine derivative and use thereof |
| 03/03/2005 | CA2536089A1 Ppar modulators |
| 03/03/2005 | CA2535714A1 Phenoxyacetic acid derivatives |
| 03/03/2005 | CA2535350A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 03/03/2005 | CA2532568A1 2-substituted pyrimidines |
| 03/02/2005 | EP1509574A1 Yellow anionic disazo dyes |
| 03/02/2005 | EP1509537A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 03/02/2005 | EP1509507A2 Mitotic kinesin inhibitors |
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 03/02/2005 | EP1509218A1 Peptide deformylase inhibitors |
| 03/02/2005 | EP1509213A2 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 03/02/2005 | EP1183091A4 Optimization of ligand affinity for rna targets using mass spectrometry |
| 03/02/2005 | EP1086082B9 Arylsubstituted olefinic amines and their use as cholinergic receptors agonists |
| 03/02/2005 | EP0871448B1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase |
| 03/02/2005 | CN1589153A Preventives/remedies for urinary disturbance |
| 03/02/2005 | CN1589149A Reduced toxicity cisplatin formulations and methods for using the same |
| 03/02/2005 | CN1589145A αv整联蛋白受体拮抗剂 αv integrin receptor antagonists |
| 03/02/2005 | CN1191248C 1-(2-naphthyl) and 1(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine D4 receptor subtype lignds |
| 03/01/2005 | US6861423 Methods of treating p38 kinase-mediated disorders with pyrido[2,3-d]pyrimidin-7-one compounds |
| 02/24/2005 | WO2005016914A1 Chemical compounds |
| 02/24/2005 | WO2005016911A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | WO2005016895A1 Novel compound of 6-methyl-3-phenethyl-3,4-dihydro-1h-quinazoline-2-thinone, its preparation and a depigmentation compositon containing the same as an effective component |
| 02/24/2005 | WO2005016894A1 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 02/24/2005 | WO2005016886A1 Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005016346A1 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 02/24/2005 | WO2005016344A1 Piperazine derivatives for the treatment of hiv infections |
| 02/24/2005 | WO2005016264A2 Diamine derivatives of quinone and uses thereof |
| 02/24/2005 | WO2004087056A3 BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ |
| 02/24/2005 | US20050043397 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 02/24/2005 | US20050043392 Moderators of mnocyte chemoattractant protein; therapy for asthma; multiple sclerosis, antiarthritic agents, atherosclerosis |
| 02/24/2005 | US20050043358 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 02/24/2005 | US20050043338 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/24/2005 | US20050043336 Quinazoline derivatives as antitumor agents |
| 02/24/2005 | US20050043334 Such as N6-(4,5-dihydrooxazol-2-yl)-N4-[3-methyl-4-(6-methylpyridin-3-yloxy)-phenyl]-quinazoline-4,6-diamine; for treatment of hyperproliferative disorders such as cancer |
| 02/24/2005 | US20050043333 Quinazolinone derivative |
| 02/24/2005 | US20050043322 For therapy of hypertension |
| 02/24/2005 | US20050043307 Novel heterocycle as agonist or antagonist for nervous systems which can contain double or triple bonds with nitrogen, oxygen or sulfur with carbon or azo groups and or salts and as modulators or receptors with carriers |
| 02/24/2005 | US20050043305 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 02/24/2005 | US20050043300 Piperazine derivatives |
| 02/24/2005 | US20050042771 Identifying non-drug targets; use in drug design for improving knowledge of drug-target and drug-non-target interactions, so that drug adverse reactions can be reduced or eliminated in drugs such as troglitazone, rosiglitazone, pioglitazone, methotrexate, atorvastatin, celecoxib, rofecoxib, cerivastatin |
| 02/24/2005 | US20050042676 Contacting sample with lysine selective agent to cap epsilon -amino group, digesting sample to produce peptide fragments, deactivating cleavage reagent, deblocking/deprotecting, then recovering fragments; solid phase synthesis; kits |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2535619A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | CA2534866A1 Piperazine derivatives for the treatment of hiv infections |
| 02/23/2005 | EP1507775A1 Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| 02/23/2005 | EP1507768A1 Aryl-alkyne compounds as herbicides |
| 02/23/2005 | EP1507756A1 Ccr9 inhibitors and methods of use thereof |
| 02/23/2005 | EP1507533A2 Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins |
| 02/23/2005 | EP1507528A2 Methods for using jnk inhibitors for treating or preventing disease-related wasting |
| 02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function |
| 02/23/2005 | EP1318146B1 Process for producing pyrimidine derivative and intermediate thereof |
| 02/23/2005 | EP1226128B1 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |